Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy BioCryst Pharmaceuticals (BCRX) stocks in Canada
Learn how to easily invest in BioCryst Pharmaceuticals stocks.
BioCryst Pharmaceuticals is a biotechnology business based in the US. BioCryst Pharmaceuticals stocks (BCRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $16.25 – an increase of 0.76% over the previous week. BioCryst Pharmaceuticals employs 246 staff and has a trailing 12-month revenue of around $114 million.
How to buy shares in BioCryst Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BCRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in BioCryst Pharmaceuticals?
- Has coronavirus impacted BioCryst Pharmaceuticals shares?
- BioCryst Pharmaceuticals shares summary
- Compare share dealing platforms
- Is BioCryst Pharmaceuticals stock a buy or sell?
- BioCryst Pharmaceuticals performance over time
- BioCryst Pharmaceuticals's financials
- How volatile are BioCryst Pharmaceuticals shares?
- Does BioCryst Pharmaceuticals pay a dividend?
- Other common questions
BioCryst Pharmaceuticals stock price (NASDAQ:BCRX)Use our graph to track the performance of BCRX stocks over time.
BioCryst Pharmaceuticals shares at a glance
|Latest market close||$14.65|
|52-week range||$8.37 - $18.48|
|50-day moving average||$12.98|
|200-day moving average||$14.31|
|Wall St. target price||$20.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.28|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy BioCryst Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BioCryst Pharmaceuticals price performance over time
|1 week (2022-01-15)||N/A|
|1 month (2021-12-23)||5.24%|
|3 months (2021-10-26)||-4.75%|
|6 months (2021-07-26)||-15.07%|
|1 year (2021-01-26)||59.93%|
|2 years (2020-01-24)||421.35%|
|3 years (2019-01-25)||50.72%|
|5 years (2017-01-26)||127.13%|
BioCryst Pharmaceuticals financials
|Revenue TTM||$114 million|
|Gross profit TTM||$-106,828,000|
|Return on assets TTM||-51.75%|
|Return on equity TTM||-1925.37%|
|Market capitalisation||$2.5 billion|
TTM: trailing 12 months
BioCryst Pharmaceuticals share dividends
We're not expecting BioCryst Pharmaceuticals to pay a dividend over the next 12 months.
BioCryst Pharmaceuticals share price volatility
Over the last 12 months, BioCryst Pharmaceuticals's shares have ranged in value from as little as $8.37 up to $18.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioCryst Pharmaceuticals's is 2.484. This would suggest that BioCryst Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BioCryst Pharmaceuticals overview
BioCryst Pharmaceuticals, Inc. , a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase I clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. BioCryst Pharmaceuticals, Inc. has collaborations and in-license relationships with the Torii Pharmaceutical Co. , Ltd.
Stocks similar to BioCryst Pharmaceuticals
BioCryst Pharmaceuticals in the news
AMC, GME among meme stocks tanking amid market carnage
Oppenheimer healthcare analysts hold an analyst/industry conference call
Unusually active option classes on open January 24th
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.